Aisah A. Aubdool
Charterhouse Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Hydropersulfides promote angiogenesis and preserve vascular function.
Journal: Redox biology
Published: March 28, 2026
C-Type Natriuretic Peptide Preserves Vascular and Cardiac Function in Sepsis.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: February 04, 2026
Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension.
Journal: Pharmacological research
Published: May 30, 2025
Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 03, 2025
Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burden.
Journal: Pharmacological research
Published: September 16, 2024
Transient Receptor Potential Canonical 5 (TRPC5): Regulation of Heart Rate and Protection against Pathological Cardiac Hypertrophy.
Journal: Biomolecules
Published: February 27, 2024
C-type natriuretic peptide is a pivotal regulator of metabolic homeostasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 25, 2022
Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independently of Nitric Oxide In Vivo.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: March 01, 2021
Multidrug resistance proteins preferentially regulate natriuretic peptide-driven cGMP signalling in the heart and vasculature.
Journal: British journal of pharmacology
Published: November 10, 2020
Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease.
Journal: The Journal of pathology
Published: March 18, 2019
Last Updated: 09/26/2026